3401 logo

Teijin Limited Stock Price

TSE:3401 Community·JP¥327.8b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3401 Share Price Performance

JP¥1,699.50
398.00 (30.58%)
JP¥1,256.00
Fair Value
JP¥1,699.50
398.00 (30.58%)
35.3% overvalued intrinsic discount
JP¥1,256.00
Fair Value
Price JP¥1,699.50
AnalystConsensusTarget JP¥1,256.00

3401 Community Narratives

AnalystConsensusTarget·
Fair Value JP¥1.26k 35.3% overvalued intrinsic discount

Global Demand For Advanced Composites Will Expand Opportunities

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
JP¥1.26k
35.3% overvalued intrinsic discount
Revenue
0.21% p.a.
Profit Margin
2.38%
Future PE
13.92x
Price in 2029
JP¥1.57k

Trending Discussion

Updated Narratives

3401 logo

3401: Modest Margin Gains And Merger Plans Will Still Signal Weak Outlook

Fair Value: JP¥1.26k 35.3% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet and fair value.

2 Risks
2 Rewards

Teijin Limited Key Details

JP¥909.2b

Revenue

JP¥646.9b

Cost of Revenue

JP¥262.3b

Gross Profit

JP¥343.9b

Other Expenses

-JP¥81.6b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-423.02
28.85%
-8.97%
92.7%
View Full Analysis

About 3401

Founded
1918
Employees
20279
CEO
Akimoto Uchikawa
WebsiteView website
www.teijin.com

Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses in Japan and internationally. The company provides aramid fibers; glass and carbon fibers, composite materials, infusion resins, adhesives, fillers and resin films, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. It also offers PC resins, polyphenylene sulfide resins, molded parts, flame retardant, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, the company provides pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system businesses. Further, the company provides implantable medical devices and regenerative medical products. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.

Recent 3401 News & Updates

Recent updates

No updates